Shinpoong Pharmaceutical Co Ltd (019175) — Cash Flow Quality Index

Latest as of March 2026: 17.74x

Shinpoong Pharmaceutical Co Ltd (019175) has a Cash Flow Quality Index of 17.74x as of March 2026. Operating cash flow of ₩6.36 Billion exceeds net income of ₩358.51 Million, indicating high earnings quality where cash backs reported profits. Explore Shinpoong Pharmaceutical Co Ltd cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

17.74x
Operating CF / Net Income

Operating Cash Flow

₩6.36 Billion
KRW

Net Income

₩358.51 Million
KRW

Data as of

Mar 2026
Most recent filing

Shinpoong Pharmaceutical Co Ltd Cash Flow Quality Index (2014–2025)

Historical Cash Flow Quality Index for Shinpoong Pharmaceutical Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shinpoong Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Shinpoong Pharmaceutical Co Ltd (2014–2025)

Year-by-year earnings quality comparison for Shinpoong Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of Shinpoong Pharmaceutical Co Ltd.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2025 1.96x ₩17.25 Billion ₩8.83 Billion ▼ -51.2%
2020 4.01x ₩20.06 Billion ₩5.00 Billion ▲ +10.3%
2019 3.63x ₩19.35 Billion ₩5.32 Billion ▼ -68.2%
2018 11.43x ₩32.05 Billion ₩2.80 Billion ▲ +1.9%
2017 11.21x ₩10.15 Billion ₩904.89 Million ▲ +67.4%
2015 6.70x ₩9.89 Billion ₩1.48 Billion ▲ +46702.3%
2014 -0.01x ₩-48.16 Million ₩3.35 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.